Peptidyl-lysine hydroxylation

pathway activity — cross-omics
GO:0017185Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Peptidyl-lysine hydroxylation pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Leukemia cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CLK3, BCDIN3D, and RPL6, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine hydroxylation activity versus CLK3 in BLOOD_Leukemia (Pearson r = -0.61).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaCLK3 →-0.541-0.419<.001<.00134
SOFT_TISSUEBCDIN3D →-0.789-1.707.007<.00124
SOFT_TISSUERPL6 →+0.359+1.401.003.00833
CNSLUM →+2.832+1.150.009<.00133
BREASTTRMT11 →+0.761+1.370.008.00733
STOMACHADAT2 →+0.982+0.845<.001.00633
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0017185 vs CLK3 — BLOOD_Leukemia

Per-sample scatter of Peptidyl-lysine hydroxylation activity vs CLK3 in BLOOD_Leukemia.

Explore this scatter interactively →

Exploration